Bioinspired platform conjugated active drug delivery

Current Drug Targets

Volumn 19, Issue 4, 2018, Pages 328-338

  Shao, Jingxin ^a,b   Xuan, Mingjun ^a,c   He, Qiang ^a   Dai, Luru ^b  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

^b NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^c INSTITUTE OF CHEMISTRY   (China)

Author keywords

Active targeting; Bio camouflage; Bioinspired; Drug delivery; Molecular motor; Self propelled nanomotors

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARBON NANOTUBE; DOXORUBICIN; DRUG CARRIER; GOLD NANOPARTICLE; LIPOSOME; MESOPOROUS SILICA NANOPARTICLE; POLYPEPTIDE; DRUG; NANOMATERIAL;

BIOLOGICAL MIMICRY; BIOTECHNOLOGY; CELL DIVISION; CELL PROLIFERATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; ELECTROPHORESIS; HYDROGEL; HYDROLYSIS; IONIC STRENGTH; NANOTECHNOLOGY; NEOPLASM; PASSIVE TARGETING; PH; PROSTATE CANCER; REVIEW; ULTRASOUND; ULTRAVIOLET RADIATION; CHEMISTRY; HUMAN; PROCEDURES;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOSTRUCTURES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS;

EID: 84991720767     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450117666160602202850     Document Type: Review

References (116)

1. Langer R, Tirrell DA. Designing materials for biology and medicine. Nature 2004; 428(6982): 487-92.
2. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotech 2007; 2(12): 751-60.
3. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011; 17(11): 1410-22.
4. Gu FX, Karnik R, Wang AZ, et al. Targeted nanoparticles for cancer therapy. Nano Today 2007; 2(3): 14-21.
5. Shangguan DH, Li Y, Tang ZW, et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 2006; 103(32): 11838-43.
6. Gao XH, Cui YY, Levenson RM, Chung LWK, Nie SM. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004; 22(8): 969-76.
7. Ashley CE, Carnes EC, Phillips GK, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particlesupported lipid bilayers. Nat Mater 2011; 10(6): 389-97.
8. Nori A, Kopeček J. Intracellular targeting of polymer-bound drugs for cancer chemotherapy. Adv Drug Deliver Rev 2005; 57(4): 609-36.
9. Wang YX, Klijn JGM, Zhang Y, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005; 365(9460): 671-79.
10. Love RR, Leventhal H, Easterling DV, et al. Side effects and emotional distress during cancer chemotherapy. Cancer 1989; 63(3): 604-12.
11. Hossen MN, Kajimoto K, Akita H, et al. Vascular-targeted nanotherapy for obesity: Unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery. J Control Release 2012; 163(2): 101-10.
12. Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anticancer drug delivery. J Control Release 2010; 148(2): 135-46.
13. Barreto JA, O’Malley W, Kubeil M, et al. Nanomaterials: Applications in cancer imaging and therapy. Adv Mater 2011; 23(12): H18-H40.
14. Langer R. Drug delivery and targeting. Nature 1998; 392(6679): 5-10.
15. Vallet-Regí M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007; 46(40): 7548-58.
16. Cheng Y, Samia AC, Meyers JD, et al. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J Am Chem Soc 2008; 130(32): 10643-47.
17. Gabizon AA. Liposome circulation time and tumor targeting: Implications for cancer chemotherapy. Adv Drug Deliver Rev 1995; 16(2-3): 285-94.
18. Liang ZX, Wu T, Lou H, et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004; 64(12): 4302-08.
19. Na K, Park KH, Kim SW, et al. Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2). J Control Release 2000; 69(2): 225-36.
20. De Cock LJ, De Koker S, De Geest BG, et al. Polymeric multilayer capsules in drug delivery. Angew Chem Int Ed 2010; 49(39): 6954-73.
21. Liu Z, Chen K, Davis C, et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 2008; 68(16): 6652-60.
22. Ganta S, Devalapally H, Shahiwala A, et al. A review of stimuliresponsive nanocarriers for drug and gene delivery. J Control Release 2008; 126(3): 187-204.
23. Bhatnagar S, Venuganti VVK. Cancer targeting: Responsive polymers for stimuli-sensitive drug delivery. J Nanosci Nanotechno 2015; 15(3): 1925-45.
24. Ficai D, Ficai A, Andronescu E. Advances in cancer treatment: Role of nanoparticles. In: Soloneski S, Larramendy ML, Eds. Nanomaterials-Toxicity and risk assessment. Tech 2015.
25. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 1989; 49(23): 6449-65.
26. Hunt CA, MacGregor RD, Siegel RA. Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations. Pharm Res 1986; 3(6): 333-44.
27. McCawley LJ, Matrisian LM. Matrix metalloproteinases: Multifunctional contributors to tumor progression. Mol Med Today 2000; 6(4): 149-56.
28. Law B, Tung CH. Proteolysis: A biological process adapted in drug delivery, therapy, and imaging. Bioconj Chem 2009; 20(9): 1683-95.
29. Meyer DE, Shin BC, Kong GA, et al. Drug targeting using thermally responsive polymers and local hyperthermia. J Control Release 2001; 74(1-3): 213-24.
30. Zhao YZ, Du LN, Lu CT, et al. Potential and problems in ultrasound-responsive drug delivery systems. Int J Nanomed 2013; 8: 1621-33.
31. Alvarez-Lorenzo C, Bromberg L, Concheiro A. Light-sensitive intelligent drug delivery systems. Photochem Photobiol 2009; 85(4): 848-60.
32. Shao JX, Xuan MJ, Si TY, et al. Biointerfacing polymeric microcapsules for in vivo near-infrared light-triggered drug release. Nanoscale 2015; 7(45): 19092-98.
33. Barhoumi A, Liu Q, Kohane DS. Ultraviolet light-mediated drug delivery: Principles, applications, and challenges. J. Control. Release 2015; 219: 31-42.
34. Unsoy G, Gunduz U, Oprea O, et al. Magnetite: From synthesis to applications. Curr Top Med Chem 2015; 15(16): 1622-40.
35. Giri S, Trewyn BG, Stellmaker MP, et al. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Ed 2005; 44(32): 5038-44.
36. Kim J, Kim HS, Lee N, et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed 2008; 47(44): 8438-41.
37. Kerr DJ, Los G. Pharmacokinetic principles of locoregional chemotherapy. Cancer Surv 1993; 17: 105-22.
38. Ficai D, Sonmez M, Albu MG, et al. Antitumoral materials with regenerative function obtained using a layer-by-layer technique. Drug Des Devel Ther 2015; 9: 1269-79.
39. Andronescu E, Ficai M, Voicu G, et al. Synthesis and characterization of collagen/hydroxyapatite: Magnetite composite material for bone cancer treatment. J Mater Sci Mater Med 2010; 21(7): 2237-42.
40. Garrastazu Pereira G, Lawson AJ, Buttini F, et al. Loco-regional administration of nanomedicines for the treatment of lung cancer. Drug Deliv 2016; 23(8): 2881-96.
41. Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med 2002; 53: 615-27.
42. Türeci Ö, Sahin U, Zwick C, et al. Identification of a meiosisspecific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci USA 1998; 95(9): 5211-6.
43. Cheng R, Feng F, Meng FH, et al. Glutathione-responsive nanovehicles as a promising platform for targeted intracellular drug and gene delivery. J. Control Release 2011; 152(1): 2-12.
44. Park JH, Saravanakumar G, Kim K, et al. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliver Rev 2010; 62(1): 28-41.
45. Veiseh O, Gunn JW, Zhang MQ. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliver Rev 2010; 62(3): 284-304.
46. Schroeder A, Heller DA, Winslow MM, et al. Treating metastatic cancer with nanotechnology. Nat Rev Cancer 2012; 12(1): 39-50.
47. Sun C, Lee JSH, Zhang MQ. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliver Rev 2008; 60(11): 1252-65.
48. Shi JJ, Votruba AR, Farokhzad OC, et al. Nanotechnology in drug delivery and tissue engineering: From discovery to applications. Nano Lett 2010; 10(9): 3223-30.
49. Kim JY, Park SJ, Lee JE, et al. Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew Chem Int Ed 2006; 45(46): 7754-58.
50. Lee JH, Huh YM, Jun YW, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007; 13(1): 95-99.
51. Parveen S, Misra R, Sahoo SK. Nanoparticles: A boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine 2012; 8(2): 147-66.
52. Dastjerdi R, Montazer M. A review on the application of inorganic nano-structured materials in the modification of textiles: Focus on anti-microbial properties. Colloids Surf B 2010; 79(1): 5-18.
53. Düffels A, Green LG, Ley SV, et al. Synthesis of high-mannose type neoglycolipids: Active targeting of liposomes to macrophages in gene therapy. Chem Eur J 2000; 6(8): 1416-30.
54. Islam T, Josephson L. Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles. Cancer Biomark 2009; 5(2): 99-107.
55. Schliwa M, Woehlke G. Molecular motors. Nature 2003; 422(6933): 759-65.
56. Vale RD, Milligan RA. The way things move: Looking under the hood of molecular motor proteins. Science 2000; 288(5463): 88-95.
57. He Q, Duan L, Qi W, et al. Microcapsules containing a biomolecular motor for ATP biosynthesis. Adv Mater 2008; 20(15): 2933-37.
58. Junge W, Müller DJ. Seeing a molecular motor at work. Science 2011; 333(6043): 704-05.
59. Kay ER, Leigh DA, Zerbetto F. Synthetic molecular motors and mechanical machines. Angew Chem Int Ed 2007; 46(1-2): 72-191.
60. Cohen RN, Rashkin MJ, Wen X, et al. Molecular motors as drug delivery vehicles. Drug Discov Today 2005; 2(1): 111-8.
61. Kinosita K, Adachi K, Itoh H. Rotation of F1-ATPase: How an ATP-driven molecular machine may work. Annu Rev Biophys Biomol Struct 2004; 33: 245-68.
62. Kojima S, Blair DF. The bacterial flagellar motor: Structure and function of a complex molecular machine. Int Rev Cytol 2004; 233: 93-134.
63. Tuteja N, Tuteja R. Prokaryotic and eukaryotic DNA helicases essential molecular motor proteins for cellular machinery. Eur J Biochem 2004; 271(10): 1835-48.
64. Vale RD. The molecular motor toolbox for intracellular transport. Cell 2003; 112(4): 467-80.
65. Hamm-Alvarez SF. Molecular motors and their role in membrane traffic. Adv Drug Deliver Rev 1998; 29(3): 229-42.
66. Takatsuki H, Rice KM, Asano S, et al. Utilization of myosin and actin bundles for the transport of molecular cargo. Small 2010; 6(3): 452-57.
67. Muhuri S, Pagonabarraga I. Lattice-gas model for active vesicle transport by molecular motors with opposite polarities. Phys Rev E 2010; 82(2): 021925.
68. Touya C, Schwalger T, Lindner B. Relation between cooperative molecular motors and active Brownian particles. Phys Rev E 2011; 83(5): 051913.
69. Song WX, He Q, Möhwald H, et al. Smart polyelectrolyte microcapsules as carriers for water-soluble small molecular drug. J Control Release 2009; 139(2): 160-6.
70. Jia Y, Dong WG, Feng XY, et al. A self-powered kinesinmicrotubule system for smart cargo delivery. Nanoscale 2015; 7(1): 82-5.
71. Barbé C, Bartlett J, Kong L, et al. Silica particles: A novel drugdelivery system. Adv Mater 2004; 16(21): 1959-66.
72. Tsapis N, Bennett D, Jackson B, et al. Trojan particles: Large porous carriers of nanoparticles for drug delivery. Proc Natl Acad Sci USA 2002; 99(19): 12001-05.
73. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat Rev Drug Discov 2008; 7(9): 771-82.
74. Khullar P, Singh V, Mahal A, et al. Bovine serum albumin bioconjugated gold nanoparticles: Synthesis, hemolysis, and cytotoxicity toward cancer cell lines. J Phys Chem C 2012; 116(15): 8834-43.
75. Ellerby HM, Arap W, Ellerby LM, et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 1999; 5(9): 1032-38.
76. Fox ME, Szoka FC, Frechet JMJ. Soluble polymer carriers for the treatment of cancer: The importance of molecular architecture. Accounts Chem Res 2009; 42(8): 1141-51.
77. Gobin AM, Lee MH, Halas NJ, et al. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett 2007; 7(7): 1929-34.
78. Huang XH, El-Sayed IH, Qian W, et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006; 128(6): 2115-20.
79. Parodi A, Quattrocchi N, van de Ven AL, et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotech 2013; 8(1): 61-8.
80. Hu CMJ, Zhang L, Aryal S, et al. Erythrocyte membranecamouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA 2011; 108(27): 10980-5.
81. Furman NET, Lupu-Haber Y, Bronshtein T, et al. Reconstructed stem cell nanoghosts: A natural tumor targeting platform. Nano Lett 2013; 13(7): 3248-55.
82. Hu CMJ, Fang RH, Luk BT, et al. Nanoparticle-detained toxins for safe and effective vaccination. Nat Nanotech 2013; 8(12): 933-8.
83. Xuan MJ, Shao JX, Dai LR, et al. Macrophage cell membrane camouflaged mesoporous silica nanoparticles for in vivo cancer therapy. Adv. Healthcare Mater 2015; 4(11): 1645-52.
84. Shao JX, Xuan MJ, Dai LR, et al. Near-infrared-activated nanocalorifiers in microcapsules: Vapor bubble generation for in vivo enhanced cancer therapy. Angew Chem Int Ed 2015; 54(43): 12782-7.
85. Hu CMJ, Fang RH, Copp J, et al. A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotech 2013; 8(5): 336-40.
86. Wang F, Gao WW, Thamphiwatana S, et al. Hydrogel retaining toxin-absorbing nanosponges for local treatment of methicillinresistant staphylococcus aureus infection. Adv Mater 2015; 27 (22): 3437-43.
87. Copp JA, Fang RH, Luk BT, et al. Clearance of pathological antibodies using biomimetic nanoparticles. Proc Natl Acad Sci USA 2014; 111(37): 13481-6.
88. Li LL, Xu JH, Qi GB, et al. Core-shell supramolecular gelatin nanoparticles for adaptive and “on-demand” antibiotic delivery. ACS Nano 2014; 8(5): 4975-83.
89. Cao BR, Yang MY, Zhu Y, et al. Stem cells loaded with nanoparticles as a drug carrier for in vivo breast cancer therapy. Adv Mater 2014; 26(27): 4627-31.
90. Laurencin M, Cam N, Georgelin T, et al. Human erythrocytes covered with magnetic core-shell nanoparticles for multimodal imaging. Adv Healthcare Mater 2013; 2(9): 1209-12.
91. Wang C, Sun XQ, Cheng L, et al. Multifunctional theranostic red blood cells for magnetic-field-enhanced in vivo combination therapy of cancer. Adv Mater 2014; 26(28): 4794-802.
92. Paxton WF, Sundararajan S, Mallouk TE, et al. Chemical locomotion. Angew Chem Int Ed 2006; 45(33): 5420-9.
93. Mei YF, Solovev AA, Sanchez S, et al. Rolled-up nanotech on polymers: From basic perception to self-propelled catalytic microengines. Chem Soc Rev 2011; 40(5): 2109-19.
94. Sánchez S, Soler L, Katuri J. Chemically powered micro-and nanomotors. Angew Chem Int Ed 2015; 54(5): 1414-44.
95. Guix M, Mayorga-Martinez, CC, Merkoçi A. Nano/micromotors in (bio)chemical science applications. Chem Rev 2014; 114(12): 6285-322.
96. Wang H, Pumera M. Fabrication of micro/nanoscale motors. Chem Rev 2015; 115(16): 8704-35.
97. Xuan MJ, Shao JX, Lin XK, et al. Self-propelled Janus mesoporous silica nanomotors with sub-100 nm diameters for drug encapsulation and delivery. Chem Phys Chem 2014; 15(11): 2255-60.
98. Xuan MJ, Wu ZG, Shao JX, et al. Near infrared light-powered Janus mesoporous silica nanoparticle motors. J Am Chem Soc 2016; 138(20): 6492-7.
99. Gao W, Kagan D, Pak OS, et al. Cargo-towing fuel-free magnetic nanoswimmers for targeted drug delivery. Small 2012; 8(3): 460-7.
100. Liu R, Sen A. Autonomous nanomotor based on copper-platinum segmented nanobattery. J Am Chem Soc 2011; 133(50): 20064-7.
101. Gibbs JG, Fragnito NA, Zhao YP. Asymmetric Pt/Au coated catalytic micromotors fabricated by dynamic shadowing growth. Appl Phys Lett 2010; 97(25): 253107.
102. Jiang HR, Yoshinaga N, Sano M. Active motion of a Janus particle by self-thermophoresis in a defocused laser beam. Phys Rev Lett 2010; 105(26): 268302.
103. Xu TL, Soto F, Gao W, et al. Ultrasound-modulated bubble propulsion of chemically powered microengines. J Am Chem Soc 2014; 136(24): 8552-5.
104. Wang W, Li SX, Mair L, et al. Acoustic propulsion of nanorod motors inside living cells. Angew Chem Int Ed 2014; 53(12): 3201-4.
105. Magdanz V, Sanchez S, Schmidt OG. Development of a spermflagella driven micro-bio-robot. Adv Mater 2013; 25(45): 6581-8.
106. Xuan MJ, Shao JX, Lin XK, et al. Light-activated Janus selfassembled capsule micromotors. Colloids Surf A Physicochem Eng Asp 2015; 482(5): 92-7.
107. Gao W, Wang J. Synthetic micro/nanomotors in drug delivery. Nanoscale 2014; 6(18): 10486-94.
108. Xuan MJ, Lin XK, Shao JX, et al. Motion-based, high-yielding, and fast separation of different charged organics in water. Chem Phys Chem 2015; 16(1): 147-51.
109. Baraban L, Makarov D, Streubel R, et al. Catalytic Janus motors on microfluidic chip: Deterministic motion for targeted cargo delivery. ACS Nano 2012; 6(4): 3383-9.
110. Campuzano S, Orozco J, Kagan D, et al. Bacterial isolation by lectin-modified microengines. Nano Lett 2012; 12(1): 396-401.
111. Garcia-Gradilla V, Sattayasamitsathit S, Soto F, et al. Ultrasoundpropelled nanoporous gold wire for efficient drug loading and release. Small 2014; 10(20): 4154-9.
112. Mhanna R, Qiu FM, Zhang L, et al. Artificial bacterial flagella for remote-controlled targeted single-cell drug delivery. Small 2014; 10(10): 1953-57.
113. Ma X, Hahn, K, Sanchez S. Catalytic mesoporous Janus nanomotors for active cargo delivery. J Am Chem Soc 2015; 137(15): 4976-9.
114. Mou FZ, Chen CR, Zhong Q, et al. Autonomous motion and temperature-controlled drug delivery of Mg/Pt-Poly (Nisopropylacrylamide) janus micromotors driven by stimulated body fluid and blood plasma. ACS Appl Mater Interfaces 2014; 6(12): 9897-903.
115. Abdelmohsen LKEA, Peng F, Tu YF, et al. Micro-and nanomotors for biomedical applications. J Mater Chem B 2014; 2(17): 2395-408.
116. Patra D, Sengupta S, Duan WT, et al. Intelligent, self-powered, drug delivery systems. Nanoscale 2013; 5(4): 1273-83.